Results 21 to 30 of about 25,001,430 (174)

Castleman’s Disease- A Case Report

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2012
Castleman’s disease(CD) is a heterogeneous group of lymphoproliferative disorders of uncertain cause presenting with lymphadenopathy. It is histologically and prognostically distinct from malignant lymph-node hyperplasia.
Md. Ismail Patwary   +5 more
doaj   +1 more source

Castelman´s disease of the neck: a case report and literature review

open access: yesThe Pan African Medical Journal, 2020
Castleman’s disease is a rare pathology, poorly understood. It is considered as a lymphoproliferative disorder, described for the first time in 1954, which may be confused with other causes of lymphadenopathy.
Amel El Korbi   +8 more
doaj   +1 more source

POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin lesions) syndrome: a South America's report POEMS (polineuropatia, organomegalia, endocrinopatia, proteína M, alterações de pele): relato sul-americano

open access: yesArquivos de Neuro-Psiquiatria, 2007
The POEMS syndrome, also known as Crow-Fukase syndrome, is an unusual systemic disorder described mainly in Asian individuals. It is characterized by the presence of (P)polyneuropathy, (O)organomegaly, (E)endocrinopathy, (M) M-protein, and (S) skin ...
Ana Claudia Celestino Leite   +3 more
doaj   +1 more source

Unicentric Castleman Disease and Pheochromocytoma [PDF]

open access: yes, 2022
Castleman disease is an uncommon and heterogenous lymphoproliferative disorder which is classified as unicentric or multicentric depending on the number of lymph nodes involved. Each type has a different clinical presentation,
Maia, Rosana   +4 more
core   +1 more source

Cytodiagnosis of Castleman′s disease: A diagnostic challenge

open access: yesMuller Journal of Medical Sciences and Research, 2016
Castleman′s disease (CD) is an uncommon cause of solitary or multiple lymphadenopathy, which may be a target for fine-needle aspiration (FNA). Because of its rarity and lack of adequate literature available on its cytomorphological findings, the ...
Muktha R Pai   +2 more
doaj   +1 more source

Castleman`s disease: clinical, histopathological and imunohistochemical characteristics [PDF]

open access: yes, 2011
Catedra Morfopatologie, USMF „Nicolae Testemiţanu”, Laboratorul Morfologia Tumorilor, Institutul OncologicThis paper represents a case of Castleman`s disease, investigated clinically, histopathologically and immunohistochemicallly.
Cernîi, Anatol   +2 more
core   +1 more source

Doença de Castleman hialino-vascular do mediastino

open access: yesRevista Portuguesa de Pneumologia, 2000
RESUMO: A doença de Castleman ou hiperplasia angiofolicular dos gânglios linfáticos, é uma entidade pouco frequente e de origem desconhecida. Dois padrões histológicos distintos foram descritos: o tipo hialinovascular e o plasmo-celular.
Ana Paula Martins, Fernando Rocha
doaj   +1 more source

Historical and pathological overview of Castleman disease [PDF]

open access: yes, 2022
Castleman disease consists of several lymphoproliferative subtypes that share some histological features in the lymph nodes. On the other hand, numerous clinical findings and etiologies make the disease challenging to understand.
Nishikori, Asami   +4 more
core   +1 more source

Hiperplasia linfóide angiofolicular – Doença de Castleman – do mediastino: Apresentação de um caso clínico

open access: yesRevista Portuguesa de Pneumologia, 2006
Resumo: A hiperplasia linfóide angiofolicular foi inicialmente descrita por Castleman como uma hiperplasia do gânglio linfático, caracterizada por folículos anormais, com centros germinativos pequenos e marcada proliferação capilar.Os autores ...
Vítor Sousa, Lina Carvalho
doaj   +1 more source

Long‐Term Outcomes After Elective Splenectomy for Haematological Disease: A 27‐Year Single‐Centre Study

open access: yesANZ Journal of Surgery, EarlyView.
Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy